Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2021 - 05 - 19 save search
AVEO Oncology Announces Positive Results from Randomized Phase 2 Study of Ficlatuzumab in Combination with Cetuximab in Pan-Refractory, Metastatic HNSCC
Published: 2021-05-19 (Crawled : 21:00) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 2.2%
H: 3.16%
C: -0.14%
phase 2 positive results positive results
PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX₁₀₀ Development Program
Published: 2021-05-19 (Crawled : 21:00) - biospace.com/
PYPD | $4.5 4.65% 4.44% 1.3K
|
Health Technology
|
| O: 3.26%
H: 1.05%
C: 0.42%
fda positive
Allogene Therapeutics CD19 Forum Highlights Positive Results from Phase 1 Studies of ALLO-501 and ALLO-501A in Relapsed/Refractory Non-Hodgkin Lymphoma and Plan to Initiate Pivotal Study in 2021
Published: 2021-05-19 (Crawled : 21:00) - globenewswire.com
ALLO | $3.48 0.58% 0.57% 2M
|
Health Technology
|
| O: 11.52%
H: 0.06%
C: -15.43%
positive results phase 1 positive results phase 3
Applying Our Position As A Technology Leader To Do Good In The Community
Published: 2021-05-19 (Crawled : 14:00) - pensaregrp.com
AVCT | $0.598 -11.01% 0.33% 0
|
Finance
|
| O: -0.99%
H: 3.2%
C: 1.33%
technology positive
Why the Scarcity Of Gold Could Lead To Positive Gains Over Next 10 Years
Published: 2021-05-19 (Crawled : 13:00) - prnewswire.com
NEM | $39.02 1.22% 0.0% 10M
|
Non-Energy Minerals
|
| O: -0.65%
H: 1.91%
C: -0.32%
KGC | $6.77 3.99% 0.16% 24M
|
Non-Energy Minerals
|
| O: -1.09%
H: 2.4%
C: -1.48%
HL | $5.31 0.57% 0.38% 6.3M
|
Non-Energy Minerals
|
| O: -2.04%
H: 3.01%
C: 0.0%
GFI | $17.65 -0.68% 0.0% 5.2M
|
Non-Energy Minerals
|
| O: 1.84%
H: 3.09%
C: -2.39%
positive
Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers
Published: 2021-05-19 (Crawled : 12:15) - biospace.com/
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 1.75%
H: 2.41%
C: 2.41%
phase 1 positive phase 3 phase 2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.